LinkBIO Co.
Latest round
- Seed
Last raised
- Oct 2020
Total raised
- Undisclosed
Investors
- 1
About LinkBIO Co.
, Ltd. supports the development of new drugs, diagnostic drugs, reagents for regenerative medicine, etc. through joint or commissioned research and development. LinkBIO uses proprietary molecular separation technology developed by Prof. Yoshimoto of Tokyo University to carry out support for new drug discoveries which can provide great improvement of the visibility and concentration efficiency of the screening process (seed molecule) for the new drug candidate at the early stages. In particular, the company supplies nucleic acid aptamer (a molecule that binds to the target molecule) using the SELEX method or the MACE (Magnetic Assisted Capillary Electrophoresis Separation) method. Using aptamer is low-cost, allows screening at shorter periods of time, and does not degrade. Nucleic acid-based drugs can be created from chemical compounds, and is superior in terms of research and development speed, and safety of the product quality, compared to protein-based drugs such as antibodies, and producing them is relatively easy. Among which, Aptamer is being noticed because it has a special property of neutralizing drugs and makes it hard to induce immunization.
Who invested in LinkBIO Co.
1 investor across 1 round
See all investors in LinkBIO Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Oct 19, 2020
Amount
Undisclosed
Investors
Questions about LinkBIO Co.
Who invested in LinkBIO Co.?
LinkBIO Co. has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has LinkBIO Co. raised?
LinkBIO Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did LinkBIO Co. last raise money?
LinkBIO Co.'s most recent round on record is a Seed, in Oct 2020.
What does LinkBIO Co. do?
LinkBIO Co. is a pharmaceuticals company.
Where is LinkBIO Co. headquartered?
LinkBIO Co. is headquartered in Toride, Japan.
Which VCs invest in companies like LinkBIO Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back pharmaceuticals companies at LinkBIO Co.'s stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Seed
Raising like LinkBIO Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.